OneStep Fecal Occult Blood RapiDip InstaTest. Cat # 13020-1



Similar documents
Chapter. Guaiac Screening CHAPTER 4: GUAIAC TESTING SCREENING FOR OCCULT BLOOD. Page 1 of 5 Guaiac doc 6/24/2005

SAMPLE PROCEDURE , 09/11

Contents. Approved by: Kent Lewandrowski, M.D. 6/1/2005 Written/Updated by: Gino Pagnani Date: 4/3/09

CK-MB TEST CARD 004A302

ABORhCard. ABORhCard Package Insert ABO and Rh Blood Grouping Device

Chapter 14 Urinalysis, Body Fluids and Other Specimens. Objectives:

Albumin ELISA Kit. Albumin ELISA Kit. Zur in vitro Bestimmung des Albumin in Urin und Stuhl

This is a Waived Complexity test for Urine, and Moderately Complex for Serum.

URINE DIPSTICK Multistix 10SG

Mouse IgM ELISA. Cat. No. KT-407 K-ASSAY. For the quantitative determination of IgM in mouse biological samples. For Research Use Only. 1 Rev.

IgM ELISA. For the quantitative determination of IgM in human serum and plasma. For Research Use Only. Not For Use In Diagnostic Procedures.

How Does a Doctor Test for AIDS?

Dot Blot Analysis. Teacher s Guidebook. (Cat. # BE 502) think proteins! think G-Biosciences

Title: Glucose Testing: StatStrip Glucose Meter Page 1 of 6

LAB 14 ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)

POC.PC.17 Point of Care Testing AMNISURE PROCEDURE FOR RUPTURED FETAL MEMBRANES TABLE OF CONTENTS. 1.0 Principle of Procedure.. 2

IgE (Human) ELISA Kit

TRIIODOTHYRONINE (T3) ELISA Kit Protocol

Carcinoembryonic Antigen (CEA)

STANDARD OPERATING PROCEDURE

Anti-Zona Pellucida Antibody Latex Agglutination Test

STEP-BY-STEP INSTRUCTIONS FOR INVESTIGATIONAL USE. Rapid HCV Antibody Test FOR ORAQUICK RAPID HCV ANTIBODY TEST

Diagnosis of HIV-1 Infection. Estelle Piwowar-Manning HPTN Central Laboratory The Johns Hopkins University

Evaluation of the ABAcard HemaTrace for the Forensic Identification of Human Blood

Direct Testing Systems and Serology

Cold Agglutination Titer detecting Cold Reacting Antibodies

Lab 2. Spectrophotometric Measurement of Glucose

PROCEDURE COVERSHEET. Document Section: CHEMISTRY Author: JOANNE WONG Date Authored: JAN In Use Date: 2/1/2011 Discontinued Date:

LYME DISEASE. 2.5M specimen tests per year. 97% accuracy with Rockland tools

Toxoplasma gondii IgM ELISA Kit Protocol

General. What is a laboratory test? What is a waived test?

Cancer Antigen CA125 Human ELISA Kit

Immunoglobulin E (IgE) concentrations in Human. Immunoglobulin E (IgE) Human ELISA Kit

INSTRUCTIONS FOR USE HUMIRA 40 MG/0.8 ML, 20 MG/0.4 ML AND 10 MG/0.2 ML SINGLE-USE PREFILLED SYRINGE

Mouse Creatine Kinase MB isoenzyme (CKMB) ELISA

Covalent Conjugation to Cytodiagnostics Carboxylated Gold Nanoparticles Tech Note #105

Mouse Insulin ELISA. For the quantitative determination of insulin in mouse serum and plasma

Rat Fibronectin ELISA Kit

ab Protein Sumoylation Assay Ultra Kit

Cancer Antigen CA 125

510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY

PCR and Sequencing Reaction Clean-Up Kit (Magnetic Bead System) 50 preps Product #60200

Mouse glycated hemoglobin A1c(GHbA1c) ELISA Kit

Epinephrine/Norepinephrine ELISA Kit

Lyme (IgG and IgM) Antibody Confirmation

ECL Western Blotting Substrate INSTRUCTIONS FOR USE OF PRODUCTS W1001 AND W1015.

CA19-9. Enzyme immunoassay for the quantitative determination of CA19-9 in human serum or plasma Only for in-vitro diagnostic use

THE ACTIVITY OF LACTASE

Development and Validation of In Vitro Diagnostic Tests. YC Lee, Ph.D. CEO

HiPer RA Test Teaching Kit

Title: Panbio Dengue IgG Indirect ELISA Revision Date : Sep. 03, 2013

INSTRUCTIONS FOR USE HUMIRA 40 MG/0.8 ML SINGLE-USE PEN

FBS06 P30 Antigen Test for the Presence of Seminal Fluid

Direct Antiglobulin Test (DAT)

ab Albumin Human ELISA Kit

Collection Instructions for ARUP Drug Screen Kit #49204

HUMULIN 70/30 KwikPen

Quality Requirements of a Point of Care Testing Service

FECAL & GASTRIC OCCULT BLOOD TEST

Vaginal ph Test (ph Hydrion TM Paper )

Colorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society

Blood-Based Cancer Diagnostics

APPENDIX N BULK MILK TANKER SCREENING TEST FORM

Rapid Screening Tests

WESTERN BLOT DETECTION KIT Buffers and detection reagents for up to ten 10 x 10 cm 2 blots. Fluorescent detection via: Goat anti-mouse SureLight P3

Direct Antiglobulin Test (DAT)

Mouse GLP-2 ELISA. For quantitative determination of mouse GLP-2 in serum or plasma samples.

Visual Acuity. Hearing. Height and Weight. Blood Pressure MEASURED VALUE

Human Free Testosterone(F-TESTO) ELISA Kit

STANDARD OPERATING PROCEDURE FOR NOVA STAT STRIP CONNECTIVITY BLOOD GLUCOSE METERS FOR USE IN LEEDS NHS TRUST

Shipping of Infectious Substances and Patient Specimens

The kit is a sandwich enzyme immunoassay for in vitro quantitative measurement of PST in mouse tissue homogenates and other biological fluids.

Colorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society

Central Government Laboratory Department of Health and Environment

Instructions for Use. Components of the GENOTROPIN PEN 12

Title: Fingerstick Glucose by Accu-Chek Inform

Standard Operating Procedure (SOP) Work Package 8. Sample Collection and Storage

Bovine Vitamin B12 (VB12) ELISA Kit

Classic Immunoprecipitation

Objectives. Immunologic Methods. Objectives. Immunology vs. Serology. Cross Reactivity. Sensitivity and Specificity. Definitions

Rat creatine kinase MM isoenzyme (CK-MM) ELISA Kit

> IGF-1 (human) Table of Contents. Catalog # Well Enzyme Immunoassay Kit For use with human serum and plasma

UNIT: Total and Direct Bilirubin

ELISA-VIDITEST-MICROCYSTIN LR Lot: XX

PROPOSED DOCUMENT. Global Harmonization Task Force. Title: Principles of In Vitro Diagnostic (IVD) Medical Devices Classification

ab TripleStain IHC Kit: M&M&R on rodent tissue (DAB, DAB/Ni & AP/Red)

MYCOLOGY PARASITOLOGY RHEUMATOID FACTORS VIROLOGY SAMPLE COLLECTION

Hepatitis and Retrovirus. LIAISON XL Accurate detection of HIV infection. HIV Ab/Ag FOR OUTSIDE THE US AND CANADA ONLY

Making Biodiesel from Virgin Vegetable Oil: Teacher Manual

CRMC Laboratory Draw Station is located in the Out Patient Services area. We are available 6AM to 6PM daily.

Dengue IgM ELISA. For the quantitative determination of IgM-class antibodies to Dengue Virus in serum.

P R O D U C T S CATALOG

Rat creatine kinase MM isoenzyme (CK-MM) ELISA Kit

Protocol for Catalog # EK Angiotensin II (Human, Rat, Mouse, Canine) EIA Kit (range: 0-25 ng/ml)

Mix-N-Go Protein A Assays

Extraction: Separation of Acidic Substances

Measles (Rubeola) IgM ELISA Catalog No. CB (96 Tests)

Transcription:

CORTEZ DIAGNOSTICS, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 USA Tel: (818) 591-3030 Fax: (818) 591-8383 E-mail: onestep@rapidtest.com Web site: www.rapidtest.com See external label 2 C-30 C Σ=25 or 50 tests Cat. #13020-1 Test Dip: 2 C-30 C Buffer: 4 C-30 C OneStep Fecal Occult Blood RapiDip InstaTest Cat # 13020-1 INTENDED USE The Fecal Occult Blood test is a qualitative test that detects human hemoglobin in human fecal specimens. The test is a visual one step, in-vitro assay. It is intended for professional use to help diagnose gastrointestinal bleeding. SUMMARY AND EXPLANATION Colorectal cancer is the third most common cancer in the world. Fecal occult blood is generally defined as a blood loss of less than 50 ng/ml. The appearance of occult blood in human fecal specimen is often associated with gastrointestinal diseases which might cause colorectal cancer if not treated promptly and properly. The traditional guaiac-based method lacks sensitivity and specificity, and has diet restrictions prior to the testing. The Fecal Occult Blood Test uses the technology of immunochromatographic sandwich assay. The test is more sensitive and more specific than the traditional guaiac assay. It is easier to interpret the result. In addition, unlike the guaiac assays, the accuracy of the test is not affected by the diet of the patients. TEST PRINCIPLE The Fecal Occult Blood Test is composed of two units, a fecal collection tube and a test device. A fecal specimen is collected in the collection tube containing sample extraction buffer, and then added to the test device. When sample is added to sample pad, it moves through the conjugate pad and mobilizes the gold anti-h hemoglobin antibody conjugate that is coated on the conjugate pad. The mixture moves along the membrane by capillary action and reacts with anti-h hemoglobin antibody that is coated on the test region. If h hemoglobin is present at levels of 50 ng/ml or greater, the result is the formation of a COR Code # 21 1

colored band in the test region. If there is no h hemoglobin in the sample, the area will remain colorless. The sample continues to move to the control area where goat anti-mouse IgG antibody will capture goldantibody conjugate to form a pink to purple color, indicating the test is working and the result is valid. MATERIAL PROVIDED 1. Fecal Occult Blood Test device The amount of each coated antigen and/or antibody on the strip is less than 1.0 mg for antigen conjugate and is less than 1.0 mg for goat anti-mouse IgG antibody. Test zone: contains mice monoclonal anti-hemoglobin antibody. Control zone: contains goat anti-mouse IgG antibody. Conjugate pad: contains gold-mice monoclonal anti-hemoglobin antibody conjugate. 2. Fecal specimen collection tube The collection tube contains 2 ml of 50 mm Tris buffer, ph 7.6. 3. Instructions for use MATERIALS REQUIRED BUT NOT SUPPLIED 1. Timer or clock. STORAGE 1. Store the test device in the original sealed pouch and the fecal specimen collection tube at 4 to 30 o C. Do Not Freeze. 2. The expiration date given was established under these storage conditions. 3. The test device should remain in its original sealed pouch until ready for us. 4. The device is designed for single use. Once the pouch is opened, the device must be tested as soon as possible and cannot be reused. PRECAUTIONS 1. For in-vitro diagnostic use only. 2. Do not use product beyond the expiration date. 3. Handle all specimens as potentially infectious. PATIENT PREPARATION 1. Specimen should not be collected during or within three days of a menstrual period, or if the patient suffers from bleeding hemorrhoids or blood in the urine. 2. Alcohol, aspirin and other medications, taken in excess, may cause gastrointestinal irritation resulting in occult bleeding. Such substances should be discontinued at least 48 hours prior to testing. 3. Dietary restrictions are not necessary. SPECIMEN COLLECTION 1. Stool specimens can be collected at any time of the day. 2. Collect a random sample of feces in a clean, dry receptacle. 3. Unscrew the top of the collection tube and remove the applicator stick. 4. Insert the stick into the fecal specimen at several different sites. 5. Remove the excess sample from the stick by gently wiping with an absorbent tissue. 6. Replace the stick in the tube and tighten securely. SPECIMEN STABILITY The sample can be stored at room temperature (8-30 o C) up to seven days if not immediately tested. If the condition allowed, the sample can also be refrigerated (2 8 o C) for better storage. COR Code # 21 2

QUALITY CONTROL 1. It is recommended that a positive control, with a level between 50 200 ng/ml h hemoglobin and a negative control, 0 ng/ml h hemoglobin, be used. Control materials, which are not provided with this test kit, are commercially available. 2. The control band is an internal reagent and procedural control. It will appear if the test has been performed correctly and the reagents are reactive. You should always follow local, state and federal guidelines for running QC. PROCEDURE 1. Bring all materials and specimens to room temperature (8 30ºC). 2. Remove the test card from the sealed foil pouch. 3. Shake the collection tube vigorously to ensure a good liquid suspension. 4. Holding the tube upright with tip pointed toward the direction away from the test performer; snap off the tip. 5. Hold the tube in a vertical position and add no less than 10 drops of the sample to a clean test tube. 6. Immerse the strip into the sample with the arrow pointing toward the sample. 7. You may leave the strip in the sample or the strip out after a minimum of 30 seconds in the sample and lay the strip on a flat non-absorptive surface. 8. Read the result between 3 and 10 minutes. INTERPRETATION OF RESULTS Positive: If two colored bands are visible within 3 minutes, the test result is positive and valid. Note: Specimens containing very low levels of h hemoglobin may develop two colored bands over 10 minutes. Negative: If test area has no colored band and the control area displays a colored band, the result is negative and valid. Invalid result: The test result is invalid if a colored band does not form in the control region. The sample must be retested using a new test device. LIMITATIONS OF THE PROCEDURE 1. A number of conditions, as mentioned in Patient Preparation, can cause false positive results. 2. As with all diagnostic tests, a definitive clinical diagnosis should not be based on the result of a single test, but should only be made by the physician after all clinical and laboratory findings have been evaluated. PERFORMANCE CHARACTERISTICS A. Sensitivity: The analytical sensitivity of the test is 50 ng/ml h hemoglobin or 12.5 µg h hemoglobin/gram feces. B. Specificity: The test is specific to human hemoglobin. Samples containing the following substances were tested on both positive and negative controls with no effect on test results. COR Code # 21 3

Substances Beef hemoglobin Chicken hemoglobin Goat hemoglobin Horse hemoglobin Pork hemoglobin Rabbit hemoglobin Horseredish peroxidase Concentrations C. Interference testing: The following substances were added to h hemoglobin free and 50 ng/ml controls. No interference was found with any of the substances at the following concentrations: Acetaminophen Acetylsalicyclic acid Ampicillin Ascorbic acid Atropine Caffeine Gentisic acid Glucose Human albumin Urea Uric acid 20 mg/dl 20 mg/dl 2000 mg/dl 2000 mg/dl 4000 mg/dl 10 mg/dl REFERENCES 1. Simon J.B. Occult blood screening for colorectal carcinoma: a critical review, Gastroenterology Vol. 88 820, 1985. 2. Woo. H. and McDonald C. Detection of fecal occult blood using monoclonal antibodies, Gasteroenterology society of Australia, Annual general Meeting. Melbourne, Victoria, Australia, May 1986. 3. Adams, E.C. and Layman, K.M. Immunochemical confirmation of gastrointestinal bleeding, Ann. Elin. Lab. Sci., Vol. 4 343, (1974). 4. Ribet, A., et al. Occult-blood test and colorectal tumors, Lancet, Vol. 1, 417, (1980). 5. Taranen, M.J., et al. Immunological detection of fecal occult blood in colorectal cancer, Br. J. Cancer, Vol. 49 141, (1984). Date Adopted Reference No. 2007-12-005 DA-Fecal Occult Blood -2008 CORTEZ DIAGNOSTICS, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 ISO 13485-2003 Revision Date: 1/27/09 COR Code # 21 4

COR Code # 21 5